Yoshino I - Search Results

1

The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis.

Tanaka Y, Maniwa Y, Sugio K, Okamoto T, Nibu KI, Omori T, Endo S, Kuwano H, Chida M, Toh Y, Okada M, Shiotani A, Yoshino I. Tanaka Y, et al. Among authors: yoshino i. Interdiscip Cardiovasc Thorac Surg. 2023 Apr 3;36(4):ivad053. doi: 10.1093/icvts/ivad053. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37018143 Free PMC article.

2

Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancer.

Yano T, Sugio K, Yamazaki K, Kase S, Yamaguchi M, Ondo K, Yoshino I, Sugimachi K. Yano T, et al. Among authors: yoshino i. Lung Cancer. 1999 Dec;26(3):143-8. doi: 10.1016/s0169-5002(99)00082-3. Lung Cancer. 1999. PMID: 10598924 Clinical Trial.

3

Heterogeneous distribution of P53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression, rather than with P53 gene mutation.

Koga T, Hashimoto S, Sugio K, Yoshino I, Nakagawa K, Yonemitsu Y, Sugimachi K, Sueishi K. Koga T, et al. Among authors: yoshino i. Int J Cancer. 2001 Jul 20;95(4):232-9. doi: 10.1002/1097-0215(20010720)95:4<232::aid-ijc1040>3.0.co;2-5. Int J Cancer. 2001. PMID: 11400116

4

High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression.

Ushijima C, Tsukamoto S, Yamazaki K, Yoshino I, Sugio K, Sugimachi K. Ushijima C, et al. Among authors: yoshino i. Lung Cancer. 2001 Nov;34(2):233-41. doi: 10.1016/s0169-5002(01)00246-x. Lung Cancer. 2001. PMID: 11679182

5

Clinical significance of serum TH1/TH2 cytokines in patients with pulmonary adenocarcinoma.

Yamazaki K, Yano T, Kameyama T, Suemitsu R, Yoshino I, Sugio K. Yamazaki K, et al. Among authors: yoshino i. Surgery. 2002 Jan;131(1 Suppl):S236-41. doi: 10.1067/msy.2002.119795. Surgery. 2002. PMID: 11821818

6

Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.

Koga T, Hashimoto S, Sugio K, Yonemitsu Y, Nakashima Y, Yoshino I, Matsuo Y, Mojtahedzadeh S, Sugimachi K, Sueishi K. Koga T, et al. Among authors: yoshino i. Am J Clin Pathol. 2002 Mar;117(3):464-70. doi: 10.1309/CHXA-3MH0-B7FD-JGUL. Am J Clin Pathol. 2002. PMID: 11888087

7

Expression status of E-cadherin and alpha-, beta-, and gamma-catenins in thymoma.

Yoshino I, Kase S, Yano T, Sugio K, Sugimachi K. Yoshino I, et al. Ann Thorac Surg. 2002 Mar;73(3):933-7. doi: 10.1016/s0003-4975(01)03434-8. Ann Thorac Surg. 2002. PMID: 11899204

8

Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.

Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T, Sugimachi K. Tomiyasu M, et al. Among authors: yoshino i. Clin Cancer Res. 2002 Dec;8(12):3755-60. Clin Cancer Res. 2002. PMID: 12473586

9

Clinicopathologic relevance of apoptotic and proliferative factors in human lung adenocarcinoma: Fas expression correlates with the histologic subtype, but not with the degree of apoptosis.

Mojtahedzadeh S, Hashimoto S, Nakashima Y, Koga T, Matsuo Y, Yoshino I, Sugio K, Kinukawa N, Sugimachi K, Sueishi K. Mojtahedzadeh S, et al. Among authors: yoshino i. Pathol Res Pract. 2002;198(10):645-54. doi: 10.1078/0344-0338-00316. Pathol Res Pract. 2002. PMID: 12498219

10

Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.

Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y. Shikada Y, et al. Among authors: yoshino i. Clin Cancer Res. 2003 Nov 1;9(14):5282-6. Clin Cancer Res. 2003. PMID: 14614010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters